🌍💉 Biological E Receives Full WHO Prequalification for Oral Polio Vaccine📅 Latest Pharma News | 2026

In a significant milestone for global immunization efforts, Biological E Limited has received full WHO prequalification for its Oral Polio Vaccine (OPV). This achievement enables the company to carry out complete in-house, end-to-end manufacturing, strengthening global vaccine supply chains.

🏥 What Is WHO Prequalification?

The World Health Organization (WHO) prequalification program ensures that vaccines meet international standards of:

• ✅ Quality
• 🛡 Safety
• ⚙ Efficacy
• 🌍 Global regulatory compliance

Full prequalification allows vaccines to be procured by UN agencies and global health organizations for international immunization programs.

🧬 What This Means for Biological E

With this approval, Biological E can now:

• 🏭 Manufacture OPV completely in-house
• 🔬 Control the entire production process from bulk drug substance to finished product
• 📦 Strengthen global supply reliability
• 🌍 Support worldwide polio eradication initiatives

This marks a shift toward greater self-reliance and manufacturing excellence within India’s vaccine ecosystem.

🌎 Global Impact on Polio Eradication

Polio eradication remains a major global health priority. WHO prequalification ensures that:

• 💉 Vaccines can be distributed in low- and middle-income countries
• 🚚 Supply chains remain uninterrupted
• 🛡 Quality standards are maintained consistently

Biological E’s enhanced manufacturing capability will help:

• Reduce dependency on external suppliers
• Improve availability during emergency immunization campaigns
• Support global eradication drives

📊 Strategic Significance

This milestone demonstrates:

💡 Industry Perspective

India continues to play a critical role in global vaccine supply. With WHO certification, Biological E strengthens its position as a trusted global vaccine manufacturer.

This development not only enhances India’s standing in international healthcare but also contributes significantly to the mission of global polio eradication.

🏁 Final Takeaway

✨ Full WHO prequalification achieved
✨ Complete in-house OPV manufacturing enabled
✨ Strengthened global vaccine supply
✨ Major boost to polio eradication efforts

The achievement reflects growing innovation and regulatory excellence in the Indian pharmaceutical and vaccine sector.